WASHINGTON, Feb. 13 (TNSFR) -- The University of Kentucky Cannabis Center has applied to the Drug Enforcement Administration for registration as a manufacturer of Schedule I substances. The Lexington-based institution intends to produce marijuana for scientific and medical research, aligning with DEA regulations governing cannabis cultivation for federally sanctioned studies. The application, submitted on July 1, 2024, is part of an ongoing effort to expand research into the medical and pharmace . . .

Click here for more information about our products